Direct positive chronotropic action by angiotensin II in the isolated mouse atrium

Life Sci. 2006 Jul 10;79(7):637-40. doi: 10.1016/j.lfs.2006.02.005. Epub 2006 Mar 27.

Abstract

We observed the direct positive chronotropic effect of angiotensin II in mouse atria and characterized its pharmacological property. C57BL/6J mice were anesthetized with pentobarbital and hearts were quickly excised. Atrial preparations including right and left atrium were isolated and suspended in the organ bath filled with Krebs-Henseleit solution gassed with 95% O2 and 5% CO2. Angiotensin II at concentrations of 10(-10) to 10(-6) M caused concentration-dependent increase in heart rate, and the maximal response was about 13% of that by isoproterenol. The effect was blocked by the selective AT1-receptor antagonist, losartan at concentrations of 10(-6) M, but not by the selective beta-blocker, nadolol at concentration of 10(-5) M. Furthermore, angiotensin I also caused concentration-dependent increase in heart rate, and the effect was blocked by angiotensin converting enzyme (ACE) inhibitor, captopril at concentrations of 10(-6) M. These results suggested that angiotensin I is converted to angiotensin II via ACE system in mice atria, and regulate heart rate through AT1-receptor stimulation, not by beta-adrenergic receptor.

MeSH terms

  • Adrenergic beta-Agonists / pharmacology
  • Adrenergic beta-Antagonists / pharmacology
  • Angiotensin II / pharmacology*
  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Animals
  • Captopril / pharmacology
  • Dose-Response Relationship, Drug
  • Heart / drug effects*
  • Heart Atria
  • Heart Rate / drug effects*
  • In Vitro Techniques
  • Isoproterenol / pharmacology
  • Losartan / pharmacology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nadolol / pharmacology
  • Stimulation, Chemical
  • Vasoconstrictor Agents / pharmacology*

Substances

  • Adrenergic beta-Agonists
  • Adrenergic beta-Antagonists
  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Vasoconstrictor Agents
  • Angiotensin II
  • Nadolol
  • Captopril
  • Losartan
  • Isoproterenol